Absence of β2 integrins impairs regulatory T cells and exacerbates CD4+ T cell-dependent autoimmune carditis

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2702-2710

  Haasken, Stefanie ^a   Auger, Jennifer L ^a   Binstadt, Bryce A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 INTEGRIN; CD4 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE ENDOCARDITIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; EFFECTOR CELL; ENDOCARDITIS; IMMUNOPATHOGENESIS; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REGULATORY T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD18; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDITIS; T-LYMPHOCYTES, REGULATORY;

EID: 80052671019     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000967     Document Type: Article

References (47)

1. Szekanecz, Z., and A. E. Koch. 2008. Vascular involvement in rheumatic diseases: "vascular rheumatology". Arthritis Res. Ther. 10: 224.
2. Gabriel, S. E. 2010. Heart disease and rheumatoid arthritis: understanding the risks. Ann. Rheum. Dis. 69(Suppl. 1): i61-i64.
3. Guilherme, L., J. Kalil, and M. Cunningham. 2006. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39: 31-39. (Pubitemid 43878518)
4. Goldberg, R. J., M. B. Urowitz, D. Ibañez, M. Nikpour, and D. D. Gladman. 2009. Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. J. Rheumatol. 36: 2454-2461.
5. Tenedios, F., D. Erkan, and M. D. Lockshin. 2005. Cardiac involvement in the antiphospholipid syndrome. Lupus 14: 691-696. (Pubitemid 41413293)
6. Binstadt, B. A., J. L. Hebert, A. Ortiz-Lopez, R. Bronson, C. Benoist, and D. Mathis. 2009. The same systemic autoimmune disease provokes arthritis and endocarditis via distinct mechanisms. Proc. Natl. Acad. Sci. USA 106: 16758-16763.
7. Kouskoff, V., A. S. Korganow, V. Duchatelle, C. Degott, C. Benoist, and D. Mathis. 1996. Organ-specific disease provoked by systemic autoimmunity. Cell 87: 811-822. (Pubitemid 26404281)
8. Matsumoto, I., A. Staub, C. Benoist, and D. Mathis. 1999. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286: 1732-1735. (Pubitemid 129515879)
9. Faé, K. C., D. D. Da Silva, S. E. Oshiro, A. C. Tanaka, P. M. Pomerantzeff, C. Douay, D. Charron, A. Toubert, M. W. Cunningham, J. Kalil, and L. Guilherme. 2006. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J. Immunol. 176: 5662-5670.
10. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346: 425-434.
11. Shimaoka, M., and T. A. Springer. 2003. Therapeutic antagonists and conformational regulation of integrin function. Nat. Rev. Drug Discov. 2: 703-716. (Pubitemid 37361786)
12. Yonekawa, K., and J. M. Harlan. 2005. Targeting leukocyte integrins in human diseases. J. Leukoc. Biol. 77: 129-140. (Pubitemid 40315046)
13. Scharffetter-Kochanek, K., H. Lu, K. Norman, N. Van Nood, F. Munoz, S. Grabbe, M. McArthur, I. Lorenzo, S. Kaplan, K. Ley, et al. 1998. Spontaneous skin ulceration and defective T cell function in CD18 null mice. J. Exp. Med. 188: 119-131. (Pubitemid 28328611)
14. Kevil, C. G., M. J. Hicks, X. He, J. Zhang, C. M. Ballantyne, C. Raman, T. R. Schoeb, and D. C. Bullard. 2004. Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Faslpr mice from autoimmune disease. Am. J. Pathol. 165: 609-616. (Pubitemid 38971390)
15. Glawe, J. D., D. R. Patrick, M. Huang, C. D. Sharp, S. C. Barlow, and C. G. Kevil. 2009. Genetic deficiency of Itgb2 or ItgaL prevents autoimmune diabetes through distinctly different mechanisms in NOD/LtJ mice. Diabetes 58: 1292-1301.
16. Bullard, D. C., X. Hu, T. R. Schoeb, R. C. Axtell, C. Raman, and S. R. Barnum. 2005. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J. Immunol. 175: 6327-6333. (Pubitemid 41598872)
17. Bullard, D. C., X. Hu, J. E. Adams, T. R. Schoeb, and S. R. Barnum. 2007. p150/ 95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis. Am. J. Pathol. 170: 2001-2008. (Pubitemid 47339273)
18. Dugger, K. J., K. R. Zinn, C. Weaver, D. C. Bullard, and S. R. Barnum. 2009. Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 206: 22-27.
19. Leon, F., N. Contractor, I. Fuss, T. Marth, E. Lahey, S. Iwaki, A. La Sala, V. Hoffmann, W. Strober, and B. L. Kelsall. 2006. Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis. J. Immunol. 177: 6974-6982. (Pubitemid 44715063)
20. Wang, H., T. Peters, A. Sindrilaru, D. Kess, T. Oreshkova, X. Z. Yu, A. M. Seier, H. Schreiber, M. Wlaschek, R. Blakytny, et al. 2008. TGF-β-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis. J. Clin. Invest. 118: 2629-2639. (Pubitemid 351949790)
21. Kakimoto, K., T. Nakamura, K. Ishii, T. Takashi, H. Iigou, H. Yagita, K. Okumura, and K. Onoue. 1992. The effect of anti-adhesion molecule antibody on the development of collagen-induced arthritis. Cell. Immunol. 142: 326-337.
22. Watts, G. M., F. J. Beurskens, I. Martin-Padura, C. M. Ballantyne, L. B. Klickstein, M. B. Brenner, and D. M. Lee. 2005. Manifestations of inflammatory arthritis are critically dependent on LFA-1. J. Immunol. 174: 3668-3675. (Pubitemid 40354077)
23. + T regulatory cells. J. Immunol. 175: 7889-7897.
24. Wohler, J., D. Bullard, T. Schoeb, and S. Barnum. 2009. LFA-1 is critical for regulatory T cell homeostasis and function. Mol. Immunol. 46: 2424-2428.
25. Ding, Z. M., J. E. Babensee, S. I. Simon, H. Lu, J. L. Perrard, D. C. Bullard, X. Y. Dai, S. K. Bromley, M. L. Dustin, M. L. Entman, et al. 1999. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J. Immunol. 163: 5029-5038. (Pubitemid 29501271)
26. 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 5: 653-666.
27. Nguyen, L. T., J. Jacobs, D. Mathis, and C. Benoist. 2007. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum. 56: 509-520.
28. Akilesh, S., S. Petkova, T. J. Sproule, D. J. Shaffer, G. J. Christianson, and D. Roopenian. 2004. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J. Clin. Invest. 113: 1328-1333. (Pubitemid 39069932)
29. Korganow, A. S., H. Ji, S. Mangialaio, V. Duchatelle, R. Pelanda, T. Martin, C. Degott, H. Kikutani, K. Rajewsky, J. L. Pasquali, et al. 1999. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10: 451-461. (Pubitemid 29205481)
30. Morgado, M. G., P. Cam, C. Gris-Liebe, P. A. Cazenave, and E. Jouvin-Marche. 1989. Further evidence that BALB/c and C57BL/6 γ2a genes originate from two distinct isotypes. EMBO J. 8: 3245-3251. (Pubitemid 19273550)
31. + regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells. J. Immunol. 186: 1546-1553.
32. Monte, K., C. Wilson, and F. F. Shih. 2008. Increased number and function of FoxP3 regulatory T cells during experimental arthritis. Arthritis Rheum. 58: 3730-3741.
33. Nimmerjahn, F., and J. V. Ravetch. 2006. Fcγ receptors: old friends and new family members. Immunity 24: 19-28. (Pubitemid 43077197)
34. Monach, P. A., P. A. Nigrovic, M. Chen, H. Hock, D. M. Lee, C. Benoist, and D. Mathis. 2010. Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor g, the receptor for C5a, and lymphocyte function-associated antigen 1. Arthritis Rheum. 62: 753-764.
35. Choi, J. H., Y. Do, C. Cheong, H. Koh, S. B. Boscardin, Y. S. Oh, L. Bozzacco, C. Trumpfheller, C. G. Park, and R. M. Steinman. 2009. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J. Exp. Med. 206: 497-505.
36. Noss, E. H., and M. B. Brenner. 2008. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol. Rev. 223: 252-270. (Pubitemid 351986192)
37. Desai, D. D., S. O. Harbers, M. Flores, L. Colonna, M. P. Downie, A. Bergtold, S. Jung, and R. Clynes. 2007. Fcg receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. J. Immunol. 178: 6217-6226. (Pubitemid 46717404)
38. Harbers, S. O., A. Crocker, G. Catalano, V. D'Agati, S. Jung, D. D. Desai, and R. Clynes. 2007. Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J. Clin. Invest. 117: 1361-1369. (Pubitemid 46718424)
39. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10: 1969-1980.
40. Tang, Q., J. Y. Adams, A. J. Tooley, M. Bi, B. T. Fife, P. Serra, P. Santamaria, R. M. Locksley, M. F. Krummel, and J. A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7: 83-92. (Pubitemid 41823872)
41. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 105: 10113-10118.
42. 2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritis. J. Immunol. 184: 3917-3926.
43. Jordan, J. K. 2005. Efalizumab for the treatment of moderate to severe plaque psoriasis. Ann. Pharmacother. 39: 1476-1482. (Pubitemid 41197129)
44. Tom, W. L., M. D. Miller, M. Y. Hurley, T. Suneja, G. Kudva, C. L. Leonardi, and J. M. Obadiah. 2006. Efalizumab-induced autoimmune pancytopenia. Br. J. Dermatol. 155: 1045-1047. (Pubitemid 44564518)
45. Kwan, J. M., A. M. Reese, and J. P. Trafeli. 2008. Delayed autoimmune hemolytic anemia in efalizumab-treated psoriasis. J. Am. Acad. Dermatol. 58: 1053-1055.
46. Wendt, M., J. Wohlrab, S. Zierz, and M. Deschauer. 2009. Efalizumab-induced isolated cerebral lupus-like syndrome. Neurology 72: 96-97.
47. Fujita, K., K. Kobayashi, and F. Okino. 1988. Juvenile rheumatoid arthritis in two siblings with congenital leucocyte adhesion deficiency. Eur. J. Pediatr. 148: 118-119.